Sunak's 'balancing act': Tax rises, spending, and boost for house buyers

A snapshot of what to expect on taxes, investment, green bonds, stamp duty and more

FibroGen, Inc. (0IL8.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

51.03+1.67 (+3.39%)

At close: 3:31PM GMT

Loading interactive chart…

Simply Wall St.
Could The FibroGen, Inc. (NASDAQ:FGEN) Ownership Structure Tell Us Something Useful?
If you want to know who really controls FibroGen, Inc. ( NASDAQ:FGEN ), then you'll have to look at the makeup of its...
Simply Wall St.
Who Has Been Buying FibroGen, Inc. (NASDAQ:FGEN) Shares?
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that...
Motley Fool
Why FibroGen Got Mashed on Monday
On Monday, investors pushed down its stock price by 9%. The company announced that the Food and Drug Administration's (FDA) review of the company's new drug application (NDA) for roxadustat has been extended by three months. As the original action date was today, investors are coping with the one-two disappointment of FibroGen's failure to get a regulatory present in time for the holidays, and of roxadustat's inability to barrel into the new year as a marketable drug.